Top Insider Buys: Medical & Biotech Stocks

by Hisham S. Ayoub, DMD
BioHealth Investor



Following data represents stock purchases by company insiders during the past week. This report may not be accurate or complete, and readers should not base their investment decisions on the following information.



October 1 - October 5

MannKind Corp (MNKD): Oct 2, $9.41 by Chairman & CEO
Noven Pharm (NOVN): Oct 1, $16.05 by OSS Capital Management
TLC Vision (TLCV): Oct 3, $3.00 by Strand Advisors
Par Pharm (PRX): Oct 3-5, $18.19-$18.70 by CEO, COO, & other directors
Trimeris (TRMS): OCt 1, $7.78 by Healthcor Management
Harvard Bioscience (HBIO): Oct 1, $4.43 by Skystone Advisors & HSO Limited


To keep up with the latest updates please subscribe:
Subscribe by Feed
Subscribe by Email




BioHealth Investor.com
___________________